Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
5 Revealing Analyst Questions From Natera’s Q2 Earnings Call
Via StockStory
Topics Earnings
Exposures Financial Product Safety
5 Insightful Analyst Questions From Hertz’s Q2 Earnings Call
Via StockStory
Topics Earnings Product Recall
Exposures Financial Legal Product Safety
5 Must-Read Analyst Questions From Artivion’s Q2 Earnings Call
Via StockStory
Topics Earnings
Exposures Financial Product Safety
Retail Traders Pile Into Creative Medical After FDA Fast Tracks Degenerative Disc Disease Therapy
Via Stocktwits
Tickers CELZ
Exposures Product Safety
5 Insightful Analyst Questions From Solventum’s Q2 Earnings Call
Via StockStory
Topics Earnings Product Recall
Tickers MMM
Exposures Financial Legal Product Safety
3 Reasons We’re Fans of DexCom (DXCM)
Via StockStory
Topics Stocks
Tickers DXCM
Exposures Product Safety US Equities
Allogene Q2 Cash Tops $300 Million
Via The Motley Fool
Tickers ALLO
Exposures Product Safety
The Book That Breaks the Silence: From Error to Error Exposes the Truth
Via Get News
Topics Product Recall
Exposures Legal Product Safety
Elvish Red Light Introduces FDA-Class II Medical-Grade LED Therapy Panels for Superior Wellness at Home
Via AB Newswire
Exposures Product Safety Regulatory
Hyperfine HYPR Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Artificial Intelligence Earnings
Tickers HYPR
Exposures Artificial Intelligence Financial Product Safety
HeartBeam Cuts Costs Awaits FDA Decision
Via The Motley Fool
Tickers BEAT
Exposures Product Safety
HeartBeam (BEAT) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Artificial Intelligence Earnings
Tickers BEAT
Exposures Artificial Intelligence Financial Product Safety
Tenon Medical (TNON) Q2 2025 Earnings Transcript
Via The Motley Fool
Tickers TNON
Exposures Product Safety
IceCure Medical Advances FDA Review
Via The Motley Fool
Tickers ICCM
Exposures Product Safety
Hyperfine Inc (NASDAQ:HYPR) Reports Mixed Q2 2025 Earnings: Revenue Misses but Margins Improve
Via Chartmill
Tickers HYPR
Exposures Product Safety
HeartBeam Inc (NASDAQ:BEAT) Reports Q2 2025 Results: Narrower Loss, FDA Progress, and Mixed Market Reaction
Via Chartmill
Tickers BEAT
Exposures Product Safety
Spectral Ai Posts 32% Revenue Drop in Q2
Via The Motley Fool
Tickers MDAI
Exposures Product Safety
IceCure (ICCM) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Tickers ICCM
Exposures Financial Product Safety
Levi & Korsinsky Reminds Capricor Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 15, 2025 - CAPR
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in Replimune Group, Inc. Lawsuit - REPL
Via NewMediaWire
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in Replimune Group, Inc. Lawsuit - REPL
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Levi &amp; Korsinsky Reminds Capricor Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 15, 2025 - CAPR
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
From Novel Therapies To Treat Suicidal Bipolar Depression To Launching A Network Of Clinics, NRx Pharmaceuticals Is Getting Attention On Wall Street
Via NewMediaWire
Tickers NRXP
Exposures Product Safety
From Novel Therapies To Treat Suicidal Bipolar Depression To Launching A Network Of Clinics, NRx Pharmaceuticals Is Getting Attention On Wall Street
Via TheNewswire.com
Tickers NRXP
Exposures Product Safety
Cognition Therapeutics Surges 30% Pre-Market After FDA Backs Phase 3 Trial Design For Alzheimer's Drug
Via Benzinga
Tickers CGTX
Exposures Product Safety
A Non-Invasive Solution to a Confident Neckline: Botox for Platysmal Bands
Via 24-7 Press Release
Exposures Product Safety
Insmed Stock Closes At Nearly 25-Year High As Analysts Get Bullish On FDA Nod For Lung Disease Drug: Retail Traders Ecstatic
Via Stocktwits
Tickers BAC INSM RY TSX:RY WFC
Exposures Product Safety
The 5 Most Interesting Analyst Questions From Vertex Pharmaceuticals’s Q2 Earnings Call
Via StockStory
Topics Earnings Retirement
Exposures Financial Pension Product Safety
REGN Q2 Deep Dive: New Indications and Pipeline Progress Offset EYLEA Challenges
Via StockStory
Tickers REGN
Exposures Product Safety
Vicarious Surgical Narrows Loss in Q2
Via The Motley Fool
Topics Intellectual Property
Tickers RBOT
Exposures Intellectual Property Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.